Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' Neuren Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Neuren Pharmaceuticals Limited since January 2007.
– Provides intelligence on Neuren Pharmaceuticals Limited's M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Neuren Pharmaceuticals Limited and its subsidiaries since 2007. – Information about key financial and legal advisors for Neuren Pharmaceuticals Limited's financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes Neuren Pharmaceuticals Limited's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Neuren Pharmaceuticals Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Neuren Pharmaceuticals Limited’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive,...
The APAC advanced planning and scheduling (APS) software market is expected to grow from US$ 432.75 million in 2020 to US$ 917.09 million by 2028; it is estimated to grow at a CAGR of 10.0% from 2021 to 2028. Manufacturing operations digitalization is expected fuel the APAC advanced planning and scheduling (APS) software market growth. Digital...
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest...
The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2021 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest licensing...
The manufacturing execution system market is expected to grow from USD 11.5 billion in 2021 to USD 17.1 billion by 2026 at a CAGR of 8.3% from 2021 to 2026. A few key factors driving the growth of this market include increasing use of industrial automation in process and discrete industries, increasing IT and OT convergence, and the need for...
266 pages •
By Asia Market Information & Development Company
• Jul 2021
China’s demand for Fasteners has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
The Neurodegenerative Disease market was valued at approximately USD 39.24 billion in 2020 and is expected to witness a revenue of USD 44.90 billion in 2026, with a CAGR of 2.30% over the forecast period. The COVID-19 impact on the Neurodegenerative Disease market is expected to be significant as the pandemic has impacted the workflows...
Executive Summary Global Hexamethyldisilazane Market was valued at USD 202.32 Million and xx Kilotonne by volume in the year 2020. Hexamethyldisilane (HMDS) is an organosilicon compound used as a reagent or precursor to bases and is primarily used as a silylating agent in the process of manufacturing pharmaceutical drugs...
Gross Domestic Product
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.